Top Markets
#1 CyberDEX CyberDEX +391.95%
#2 OVERTAKE OVERTAKE +58.99%
#3 Clearpool Clearpool +25.94%
#4 Playnance Playnance +23.93%
#5 deBridge deBridge +22.97%
#6 B3 (Base) B3 (Base) +20.83%
#7 Nillion Nillion +19.56%
#8 AUKI AUKI +19.09%
#9 Codatta Codatta +17.25%
#10 龙虾 (Lobster) 龙虾 (Lobster) +17.03%
Coin of the day
CyberDEX CyberDEX
Настройки
Язык
Pусский
Валюта
USD
Тема
Nuformix plc Nuformix plc

Nuformix plc

NFX
Ранг среди акций #41013
Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes... Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes in developing therapies for fibrotic diseases and cancer, primarily through the innovative strategy of drug repurposing. Its current development portfolio includes NXP001, which has advanced beyond Phase 1 trials for application in oncology supportive care. Additionally, the company is progressing NXP004, a novel variant of Olaparib, currently in its intellectual property generation stage for oncological indications, and NXP002, which is undergoing pre-clinical evaluation for the treatment of idiopathic pulmonary fibrosis. Nuformix also holds an option agreement with Oxilio Ltd. concerning NXP001 for its oncology applications. Established in 2008, the company maintains its operational base in London.
Цена акции
$0.00185055
Рыночная капитализация
$48.29K
Изменение (1 день)
-3.55%
Изменение (1 год)
30.31%
Страна
GB
Торговля Nuformix plc (NFX)

Категория

Healthcare
Количество находящихся в обращении акций Nuformix plc (NFX)
Количество акций в обращении на March 2026: 2.12B
Согласно последним финансовым отчетам и цене акций Nuformix plc, текущее количество акций в обращении составляет 2.12B. На конец September 2024 у компании было 787.01M акций в обращении. Количество акций в обращении обычно зависит от сплитов и обратного выкупа акций.
История количества акций в обращении Nuformix plc (NFX) с 2014 по 2026
Акции в обращении на конец каждого года
Год Акции в обращении Изменить
2026 (TTM) 2.12B 27.71%
2025 1.66B 111.05%
2024 787.01M 9.39%
2023 719.46M 20.22%
2022 598.45M 3.07%
2021 580.63M 21.71%
2020 477.06M 3.54%
2019 460.75M 23.34%
2018 373.55M 290.13%
2017 95.75M 59.34%
2016 60.09M 0.00%
2014 0.00 0.00%
Акции в обращении у аналогичных компаний или конкурентов
Компания Акции в обращении Разница Страна
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -88.03%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M -81.33%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M -77.42%
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -97.07%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH